ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "Abatacept and juvenile idiopathic arthritis (JIA)"

  • Abstract Number: 1446 • 2015 ACR/ARHP Annual Meeting

    Long-Term Effectiveness and Safety of Abatacept in Juvenile Idiopathic Arthritis: Interim Results from the Abatacept in JIA Registry

    Daniel J Lovell1, N Ruperto2, S Spalding3, JA Dare4, R Cimaz5, V Stanevica6, RK Vehe7, N Tzaribachev8, G Horneff9, M Trachana10, TA Simon11, HI Brunner12 and A Martini2, 1Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Istituto G. Gaslini Pediatria II Reumatologia, Genova, Italy, 3Cleveland Clinic, Cleveland, OH, 4University of Arkansas Medical Center, Little Rock, AR, 5Azienda Ospedaliero-Universitaria Meyer, Florence, Italy, 6Riga Stradins University, Riga, Latvia, 7University of Minnesota, Minneapolis, MN, 8Pediatric Rheumatology, Bad Bramstedt, Germany, 9Asklepios Klinik Zentrum für Allgemeine Paediatrie und Neonatologie, Sankt Augustin, Germany, 10Hippokration General Hospital, Thessaloniki, Greece, 11Bristol-Myers Squibb, Hopewell, NJ, 12Division of Rheumatology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH

    Background/Purpose: Abatacept (ABA) is a widely approved and used biologic in children with juvenile idiopathic arthritis (JIA). The purpose of this study was to describe…
  • Abstract Number: 1676 • 2012 ACR/ARHP Annual Meeting

    Abatacept As First Line Biological Treatment for Severe Juvenile Idiopathic Arthritis-Related Uveitis. A Multicenter Study

    Carolina Birolo1, Maria Elisabetta Zannin2, Svetlana Arsenyeva3, Rolando Cimaz4, Elisabetta Miserocchi5, Margarita Dubko6, Chantal Deslandre7, Fernanda Falcini8, Maria Alessio9, Francesco La Torre10, Ekaterina Denisova11, Irina Nikishina12 and Francesco Zulian13, 1Department of Pediatrics, Rheumatology Unit, University of Padua, Padua, Italy, 2Department of Pediatrics, Ophthalmology Unit, University of Padua, Padua, Italy, 3Pediatric Department, Scientific Research Institute of Rheumatology RAMS, Moskow, Russia, 4Rheumatology Unit, A. Meyer Children's Hospital, Florence, Italy, 5Department of Ophthalmology, Scientific Institute San Raffaele, University Vita-Salute, Milan, Italy, 6State Pediatric Medical University, Saint-Petersburg, Russia, 7Rheumatology, Cochin Hospital, Paris, France, 8Department of Biomedicine, Division of Rheumatology AOUC, Excellence Centre for Research, Florence, Italy, 9Department of Pediatrics, Rheumatology Unit, University of Naples Federico II, Naples, Italy, 10DIMIMP-University, Rheumatologic Section, Bari, Italy, 11Helmgoltz Moscow Recearch Institute of Eye Diseases, Moskow, Russia, 12Pediatric Department, Scientific Research Institute of Rheumatology RAMS, Moskow, Moskow, Russia, 13Department of Pediatrics, University of Padua, Padova, Italy

    Background/Purpose: Anterior uveitis is a serious complication of Juvenile Idiopathic Arthritis (JIA). Recently, Abatacept (ABA) has been used in children with JIA-uveitis who had failed…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.